During the past decade, Renstar Medical Research conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 81 clinical trials were completed, i.e. on average, 77.9% percent of trials that started reached the finish line to date. In the past 5 years, 55 clinical trials started and 50 clinical trials were completed. i.e. 90.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Renstar Medical Research" #1 sponsor was "Eli Lilly and Company" with 33 trials, followed by "Pfizer" with 23 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored, "Janssen Research & Development, LLC" with 10 trials sponsored and "Amgen" with 10 trials sponsored. Other sponsors include 89 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Renstar Medical Research" #1 collaborator was "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Alzheimer's Clinical Trials Consortium" with 2 trials as a collaborator, "Biogen" with 2 trials as a collaborator and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Renstar Medical Research" are "Alzheimer's Disease" (21 trials), "Psoriasis" (21 trials), "Alzheimer Disease" (13 trials), "Migraine" (7 trials) and "Plaque Psoriasis" (7 trials). Many other conditions were trialed in "Renstar Medical Research" in a lesser frequency.

Most popular intervention types in "Renstar Medical Research" are "Drug" (165 trials), "Other" (15 trials), "Biological" (8 trials), "Dietary Supplement" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (98 trials), "placebo" (6 trials), "Apremilast" (5 trials), "Gantenerumab" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Renstar Medical Research" are 169 trials for "All" genders, 5 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Renstar Medical Research". undefined are not yet recruiting, 18 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 118 completed trials in Renstar Medical Research, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Renstar Medical Research, 3 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 82 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 3 trials that are defined as “Not Applicable".